Neuroelectrics published a 4-week pilot case series in 5 patients with severe baseline symptoms (Y-BOCS ≥ 23) showing a 35.2% mean reduction in obsessive-compulsive symptoms and a 46.4% reduction in total DASS-21 affective symptom scores following bi-weekly frontal tACS sessions.

Public source

Publisher name

Public post

Can #tACS help patients with treatment-resistant OCD when pharmacotherapy and CBT have failed? A 4-week pilot case series in 5 patients with severe baseline symptoms (Y-…

Log in to read the full post

Company

Neuroelectrics

Reinventing brain health. Personalized technologies for brain monitoring and stimulation.

Industry
Medical Device
Location
Barcelona, ES
Company size
51–200 employees

About Neuroelectrics

Neuroelectrics® is a digital brain health company that innovates at the intersection of neuroscience, physics, machine learning, and hardware. We have developed wireless EEG and tDCS/tACS/tRNS stimulation devices with up to 32 channels, amongst other products encompassing software and research services, with the purpose of monitoring and enhancing brain health.

See more

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.